Xiidra / Oph enough is enough!!!









































He does have a point. Novartis is riding xiidra into the sunset hoping one of their pipline drugs scheduled for 2026 or 2027 actually gets through phase 3. They spent a lot of money on gyroscope. We will see if it ever comes to fruition.

lol. If you think xiidra has that long, I’ve got some land for you. This franchise is a dumpster fire that has been mismanaged since day one.
 




Hopefully we don’t have too much longer…

Anybody remember this from that Reuters article back in November?

“Any sale of the ophthalmology and respiratory businesses is likely to begin in 2023, after the process for Sandoz is completed, the Bloomberg report said.”

The Sandoz spin-off will be complete “in the second half of 2023.”
 




















Hopefully we don’t have too much longer…

Anybody remember this from that Reuters article back in November?

“Any sale of the ophthalmology and respiratory businesses is likely to begin in 2023, after the process for Sandoz is completed, the Bloomberg report said.”

The Sandoz spin-off will be complete “in the second half of 2023.”


I can’t believe I literally wrote this yesterday! Lmao
 




I can’t believe I literally wrote this yesterday! Lmao
1cba1f1df7702b52eb747aad91cdd0d5.gif
 












Similar threads

Replies
34
Views
8K
Replies
7
Views
3K
Replies
6
Views
2K
Replies
14
Views
3K
Replies
0
Views
717